Neurogenic and anti-inflammatory effects of probiotics in Parkinson's disease: A systematic review of preclinical and clinical evidence

被引:34
|
作者
Leta, Valentina [1 ,2 ]
Chaudhuri, K. Ray [1 ,2 ]
Milner, Oliver [1 ]
Chung-Faye, Guy [3 ]
Metta, Vinod [2 ]
Pariante, Carmine M. [4 ]
Borsini, Alessandra [5 ,6 ]
机构
[1] Kings Coll London, Dept Neurosci, Inst Psychiat Psychol & Neurosci, Crespigny Pk, London SE5 8AF, England
[2] Kings Coll Hosp London, Parkinsons Fdn Ctr Excellence, Denmark Hill, London SE5 9RS, England
[3] Kings Coll Hosp London, Dept Gastroenterol, London, England
[4] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England
[5] South London & Maudsley NHS Fdn Trust, Mental Hlth Biomed Res Ctr, Natl Inst Hlth Res NIHR, London, England
[6] Kings Coll London, London, England
关键词
Probiotics; Parkinson's disease; Neurodegeneration; Inflammation; Metabolism; Motor symptoms; Non-motor symptoms; GUT MICROBIOME; MOUSE MODEL; CONSTIPATION; SUPPLEMENTATION; PROGRESSION; EXPRESSION; EXENATIDE; INSULIN;
D O I
10.1016/j.bbi.2021.07.026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is increasing evidence highlighting the potential role of the gut-brain axis in the pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic strategy for this neurodegenerative disorder. While several studies have been published on the topic in recent years, there is still a lack of a comprehensive understanding of the effects of probiotics in PD and their possible underlying mechanisms. Through this systematic review, we collected a total of 17 articles, consisting of preclinical and clinical models of PD investigating the effect of probiotics on (1) energy metabolism, (2) inflammation and oxidative stress, (3) neurodegeneration, as well as (4) motor and (5) non-motor function. Articles were obtained from PubMed/Medline, Scopus, Web of Science and Embase databases. Findings from preclinical studies suggest that treatment with probiotics increases glucose metabolism (increased secretion of glucagon-like peptide-1), reduces peripheral and central inflammation (reduced interleukin-6 and tumor necrosis factor-alpha (TNF-alpha)), reduces peripheral and central oxidative stress (reduced peripheral superoxide anion levels and increased central antioxidant glutathione levels), decreases neurodegeneration (increased numbers of tyrosine hydroxylase dopaminergic neurons and levels of brainderived neurotrophic factor), increases motor function (increased motor agility) and non-motor function (decreased memory deficits). Similarly, findings from clinical studies suggest that probiotics increase glucose metabolism (reduced insulin resistance), reduce peripheral inflammation (reduced peripheral TNF-alpha expression and C-reactive protein levels), and increase motor and non-motor function (decreased overall PD symptomatology and constipation); however, findings on oxidative stress were inconclusive across studies. Overall, this review is the first one to systematically report evidence for the putative beneficial effects of probiotics on molecular and cellular mechanisms, as well as behavioural phenotypes, in either preclinical or clinical studies in PD. However, additional and more robust studies are still needed to confirm these outcomes, and should aim to focus more on bench-to-bedside approaches, in order to address the existing gaps between preclinical and clinical findings in this field.
引用
收藏
页码:59 / 73
页数:15
相关论文
共 50 条
  • [1] Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review
    Mohammad Morshedi
    Reza Hashemi
    Sara Moazzen
    Amirhossein Sahebkar
    Elaheh-Sadat Hosseinifard
    [J]. Journal of Neuroinflammation, 16
  • [2] Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review
    Morshedi, Mohammad
    Hashemi, Reza
    Moazzen, Sara
    Sahebkar, Amirhossein
    Hosseinifard, Elaheh-Sadat
    [J]. JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01)
  • [3] Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings
    Zamanian, Mohammad Yassin
    Terefe, Ermias Mergia
    Taheri, Niloofar
    Kujawska, Malgorzata
    Tork, Yekta Jahedi
    Abdelbasset, Walid Kamal
    Shoukat, Shehla
    Opulencia, Maria Jade Catalan
    Heidari, Mahsa
    Alesaeidi, Samira
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (10) : 1453 - 1461
  • [4] Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
    Vian, Camila de Oliveira
    Marinho, Marcelo Augusto Germani
    Marques, Magno da Silva
    Hort, Mariana Appel
    Cordeiro, Marcos Freitas
    Horn, Ana Paula
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (01) : 3 - 22
  • [5] Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs
    Bassani, Taysa Bervian
    Vital, Maria A. B. F.
    Rauh, Laryssa K.
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2015, 73 (07) : 616 - 623
  • [6] Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases
    Plaza-Diaz, Julio
    Javier Ruiz-Ojeda, Francisco
    Maria Vilchez-Padial, Laura
    Gil, Angel
    [J]. NUTRIENTS, 2017, 9 (06):
  • [7] A Systematic Review for Anti-Inflammatory Property of Clusiaceae Family: A Preclinical Approach
    de Melo, Monica Santos
    Siqueira Quintans, Jullyana de Souza
    de Souza Araujo, Adriano Antunes
    Duarte, Marcelo Cavalcante
    Bonjardim, Leonardo Rigoldi
    de Lima Nogueira, Paulo Cesar
    de Souza Moraes, Valeria Regina
    de Araujo-Junior, Joao Xavier
    Nogueira Ribeiro, Eurica Adelia
    Quintans-Junior, Lucindo Jose
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [8] Non-Steroidal Anti-Inflammatory Drugs and Parkinson's Disease: A Systematic Review and Meta-analysis
    Alharbi, Bandar Aqeel
    Ghazali, Jury Sami
    Alatwi, Noura Abdullah
    Alghamdi, Wafa Mohammed
    Alqahtani, Raed Mubarek
    Alqahtani, Malak Mohammad
    Alenazi, Alaa Ali Salem
    Alsafwani, Doha Jawad
    [J]. ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2020, 10 (05) : 1023 - 1028
  • [9] Novel anti-inflammatory therapy for Parkinson's disease
    Gao, HM
    Liu, B
    Zhang, WQ
    Hong, JS
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (08) : 395 - 401
  • [10] The Role of Anti-Inflammatory Agents in Parkinson’s Disease
    Edith G. McGeer
    Patrick L. McGeer
    [J]. CNS Drugs, 2007, 21 : 789 - 797